Exponent operates a high-quality engineering and consulting franchise with best-in-class margins of 20%, a perfect Piotroski financial health score, and a wide economic moat — yet the stock is in a confirmed technical downtrend and recently missed earnings estimates, creating tension between the quality of the business and near-term execution momentum. The risk/reward geometry of roughly 21% upside against 7% downside offers an asymmetric setup for investors who can absorb the trend headwind.
Thesis pillars
- Best In Class Quality Franchise↑Improving
- Favorable Asymmetric Risk Reward↓Deteriorating
- Confirmed Technical Downtrend→Stable
- +2 more pillars — see the Why tab for full reasoning
Pillars as of Jul 3, 2026, based on the 10-K filed Feb 27, 2026· older than 90 days
Exponent, Inc. (EXPO) Stock Analysis
Industrials · Engineering & Construction
Hold if already holding. Not a fresh buy at $87.43, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (0.8% away).
Our interdisciplinary team of scientists, physicians, engineers, and business consultants draws from more than 90 technical disciplines to solve the most pressing and complicated challenges facing stakeholders today. The firm leverages over 55 years of experience in analyzing... Read more
Hold if already holding. Not a fresh buy at $87.43, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (0.8% away). Chart setup: No clear chart pattern; technical signals are mixed. Mixed signals. Hold existing position. Score 5.7/10, moderate confidence.
Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 91d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.
Recent developments
updated Oct 28, 2026Recent Developments — Exponent, Inc.
Latest news
- NEWS EXPO Q3'26 Earnings: EPS estimate is 0.60 USD - TradingView — TradingView Oct 28, 2026 neutral
- NEWS Natural Products Expo West Unveils Top Trends Shaping Natural Products in 2027 - markets.businessinsider.com — markets.businessinsider.com Oct 21, 2026 neutral
- NEWS Argus raised target to USD 75 for Exponent stock - ad-hoc-news.de — ad-hoc-news.de Oct 20, 2026 positive
- NEWS Exponent (EXPO) Gets A Zacks Boost, Is 14% Undervalued? - Simply Wall Street — Simply Wall Street Oct 20, 2026 positive
- NEWS CEDIA Expo Announces Inaugural Best Booth Awards Winners - Commercial Integrator — Commercial Integrator Oct 20, 2026 neutral
Latest item Oct 28, 2026 · Generated 2026-11-05T11:44:08Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $87.43, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (0.8% away). Chart setup: No clear chart pattern; technical signals are mixed. Mixed signals. Hold existing position. Analyst target $77.07 reached (−11.9%), stop $82.23 (−6.3%), A.R:R -0.8:1. Score 5.7/10, moderate confidence.
Analyst target $77.07 reached (−11.9% from $87.43); no take-profit level is published. Analyst target $77.07 reached (−11.9%), stop $82.23 (−6.3%), A.R:R -0.8:1. Stop-loss: $82.23.
Analyst target reached - limited upside remaining; Near 52-week high (0.8% away); Sector modifier (Industrials): -0.7.
Exponent, Inc. trades at a P/E of 37.7 (forward 30.0). TrendMatrix value score: 3.5/10. Verdict: Hold.
10 analysts rate EXPO, with a consensus score of 4.1/5. 3 analysts publish price targets averaging $91.
What does Exponent, Inc. do?Our interdisciplinary team of scientists, physicians, engineers, and business consultants draws from more than 90...
Our interdisciplinary team of scientists, physicians, engineers, and business consultants draws from more than 90 technical disciplines to solve the most pressing and complicated challenges facing stakeholders today. The firm leverages over 55 years of experience in analyzing accidents and failures to advise clients as they innovate their technologically complex products and processes, ensure the safety and health of their users, and address the challenges o